Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation

A concurrent increase in the prevalence of hepatocellular carcinoma (HCC) with that of type 2 diabetes (T2D) and obesity has been reported in the absence of hepatitis B virus surface antigen-negative/hepatitis C virus antibody-negative HCC (NBNC-HCC). However, the prognostic relevance of this associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Umetsu, Satoko, Mizukami, Hiroki, Saito, Takeshi, Uchida, Chiaki, Igawa, Akiko, Kudo, Kazuhiro, Itabashi, Chieko, Osonoi, Sho, Danyang, Guo, Sasaki, Takanori, Yagihashi, Soroku, Hakamada, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981134/
https://www.ncbi.nlm.nih.gov/pubmed/31980687
http://dx.doi.org/10.1038/s41598-020-57883-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981134/
https://www.ncbi.nlm.nih.gov/pubmed/31980687
http://dx.doi.org/10.1038/s41598-020-57883-1

Ejemplares similares